Axon shares drop almost 4% after Sumitomo Mitsui Trust and Choreo reduce holdings

Traders Union
All News
Stocks
Axon drops 3.67% today on selling

Highlights

Axon projects strong year-over-year revenue growth in Connected Devices, driven by robust demand for TASER units, cameras, and premium software.
Sumitomo Mitsui Trust Group Inc. and Choreo LLC reduced their Axon holdings in the third quarter, and Zacks Research downgraded the stock.
Shares of Axon trade below key moving averages with momentum indicators confirming downside pressure; the expected five-day range is $393.5 to $427.38.

Ownership cuts and analyst downgrade reinforce selling amid strong sales outlook

Axon is scheduled to report its third-quarter 2026 earnings after market close on November 5, 2026, with the release expected at 4:01 PM ET. Recent company disclosures indicated strong demand for TASER devices, body-worn cameras, and premium software, especially in the Connected Devices segment, projected to achieve significant year-over-year revenue growth. Filings showed that Sumitomo Mitsui Trust Group Inc. and Choreo LLC both reduced their holdings in the third quarter, and Zacks Research downgraded the company’s stock rating. These developments occurred as price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, sees persistent weakness in Axon after the recent selloff and institutional outflows. He points out that trading below key moving averages and the recent downgrades from major firms show sellers remain in control. Kharitonov highlights that technical indicators confirm a bearish environment, with downside momentum overshadowing temporary intraday gains. Recent reductions by Sumitomo Mitsui Trust Group Inc. and Choreo LLC reflect waning confidence from major holders. He warns, "With pressure mounting on both technical and fundamental fronts, I see no compelling reason for near-term optimism in AXON."

Viktoras Karapetjanc, expert at Traders Union, notes that despite near-term volatility, Axon’s underlying growth in Connected Devices and demand for TASERs continues to support a positive outlook. He believes the upcoming Q3 earnings could be a catalyst, especially as the company’s fundamentals remain constructive. Karapetjanc is confident that the bullish structure can recover if price reclaims $409.4 and investor sentiment improves. He acknowledges lower institutional activity but points to strong sector dynamics driving future opportunities. "I expect further growth as the company leverages robust demand and the long-term market offers multiple setups for buyers," he says.

Parshwa Turakhiya, analyst, observes mixed sentiment in Axon's short-term price action as intraday bulls failed to reclaim resistance. He notes that while a sideways corridor dominates the setup, volatility remains high and immediate levels at $409.4 and $408.45 define the next key moves. Turakhiya highlights the potential for short-term momentum trades if a clear break occurs in either direction. "Traders should watch for breakout setups on elevated volatility with stops near the $408.45 level," he advises.

Bearish momentum extends with persistent lows and conflicting intraday signals

Axon is currently trading below its 20-, 50-, and 200-day moving averages at $415.14, $452, and $475.7 respectively, which signals sustained pressure from sellers across all timeframes. The nearest support is set at $408.45 (Ichimoku Kijun), with resistance at $409.4. The prevailing bearish long-term trend is confirmed by the MA-50 versus MA-200 alignment. Momentum indicators reflect continued selling pressure: MACD and ADX both signal sell conditions, while RSI, Stochastic RSI, and CCI remain neutral. Bull/Bear Power is positive at 7.6, indicating buyer dominance intraday, and the Awesome Oscillator is neutral. AXON has declined $15.585 or 3.67% so far today, after opening with a $2.54 upside gap, and is trading near the day’s low amid intraday volatility of 4.91%. Downside pressure persists after the open, and intraday movement is largely aligned with broader momentum signals.

Earlier, analysts noted that Axon's technical picture exhibited weakness despite signs of increased institutional participation, pointing to heightened downside risks. The latest developments reinforce the prior bearish outlook, with new institutional outflows and broad-based technical pressure heightening the importance of closely monitoring support at $408.45 for potential further weakness.

Source of Data: AXON Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.